India administers 80 lakh HPV vaccine doses

Gujarat, Uttar Pradesh, Madhya Pradesh, and Mizoram have achieved 100 per cent coverage of their respective identified target populations

India has crossed a significant milestone in its efforts to prevent cervical cancer and has administered more than 80 lakh doses of Human Papillomavirus Vaccine (HPV) under the National HPV Vaccination Campaign since its launch in February 2026. 

The milestone marks the expanding reach of HPV vaccination through the public health system and reinforces India’s commitment to strengthening preventive healthcare for adolescent girls. As per Registrar General of India (RGI) 2021 estimates, approximately 1.2 crore girls constitute the annual cohort of 14-year-olds who are expected to benefit from the initiative each year.

Gujarat, Uttar Pradesh, Madhya Pradesh, and Mizoram have achieved 100 per cent coverage of their respective identified target populations. Bihar, Andhra Pradesh, and Assam have crossed 90 per cent coverage while Karnataka has achieved more than 85 per cent coverage. Chhattisgarh, Sikkim, Kerala, Telangana, and Odisha have crossed 60 per cent coverage. Among states, Uttar Pradesh has recorded the highest number of vaccinations, with more than 22 lakh adolescent girls vaccinated under the campaign.

Madhya Pradesh and Gujarat have achieved 100 per cent coverage of their identified target cohorts, supported by sustained community mobilisation, coordinated implementation and focused field-level efforts. The progress in Assam and other Northeastern States also demonstrates the role of integrated community health networks and coordinated field-level action in expanding access across geographically diverse areas.

The campaign has placed strong emphasis on community engagement and credible information, with parents, healthcare providers, teachers and frontline health workers being actively engaged to address concerns and counter misinformation relating to HPV vaccination.

Healthcare providers, including paediatricians, gynaecologists and experts from institutions such as AIIMS, along with teachers and frontline health workers including ASHAs and ANMs, have supported awareness and mobilisation efforts across States and districts.

HPV vaccination, initially adopted predominantly by high-income countries, has progressively expanded into national immunisation programmes across countries at different income levels. At present, 87 per cent of upper-middle-income countries, 78 per cent of lower-middle-income countries and 54 per cent of low-income countries have adopted HPV vaccines in their National Immunization Programmes.

The growing adoption of HPV vaccination across diverse income settings reflects its increasing role as an important component of national strategies for cervical cancer prevention.